Member Info for roses

level 2 is moving up very swiftly, looks like there might be a decent delayed buy yet to show ?

I'm guessing that we will see another very lively day tomorrow as the £20m award is announced at midnight tomorrow ?

8.87 just paid via NEX

Nice big tick up. Looks like the long overdue re-rate is starting ?

Inanaco - my thoughts exactly, everything is falling into place.

Very encouraging news, looks like there is allot to be announced quite soon.

Just Topped up an extra 200k (looks like they have delayed them)

I think the time has come for the discussion to be switched from 'paid derampers' to 'paid rampers' .

Considering who is providing facts and is time and time again year after year to be proven right.
And on the flipside those that are just making up their own facts and time lines to support the company and continually being proven wrong.

There may be employees of the company posting on here or there may not. I will leave it up to you to decide, but to me the answer is clear. However as has been shown, it is not unprecedented.

There have been many cases where AIM company directors or employees have been found to be posting on the bulletin boards to defend their company.

It doesn't say anywhere that it is a peer review ?

Suzanne dilly just says "it's great to see Our paper published"

Mkx007 - the review is suggesting that another trial with daily doses of 2mg might be needed

"Subsequent studies to explore the pharmacokinetics after multiple and difering doses of VAL401 would provide further information, although it should be noted that both the parent risperidone and metabolite 9-hydroxyrisperidone
should be analysed throughout. Further analyses were not possible during this study due to the ethical limitations of
performing multiple blood draws from end-stage cancer patients.
The absolute Cmax value for the active moiety supports our supposition that 2 mg daily dosage would be sufcient
to assess the potential anticancer activity of VAL401, as this would allow the desired level of 20 ng/mL (as tested in the previously reported in vitro model system [9]) to be attained"

Thanks, but still looks like you have to be a premium member to access it. thanks again.

I think you need to be a premuim memeber to do that. I'll register when i get a moment and have a look, thanks anyway.

ah, you need to be registered to see it.

Harley - all I can see from Dilly on Linkedin is

"Good to see our VAL401 clinical pharmacokinetics paper published today! Particular thanks to the team at Ariana Pharmaceuticals and to Paul Taylor at Leeds University as co-authors"

No mention of ph 3 ?

It's not my opinion, it's the peer reviewers.

You don't move on to ph 3 if you intend on or need to increase the dose.

Anyhow, time will tell.

It seems the peer review is saying we need more ph 2 trials and possibly dose escalation studies and is not ready to move on to ph 3 yet.

"Subsequent studies to explore the pharmacokinetics after multiple and difering doses of VAL401 would provide further information, although it should be noted that both the parent risperidone and metabolite 9-hydroxyrisperidone
should be analysed throughout. Further analyses were not possible during this study due to the ethical limitations of
performing multiple blood draws from end-stage cancer patients.
The absolute Cmax value for the active moiety supports our supposition that 2 mg daily dosage would be sufcient
to assess the potential anticancer activity of VAL401, as this would allow the desired level of 20 ng/mL (as tested in the previously reported in vitro model system [9]) to be attained."

"read the energy preperly"

Dear god, that pretty much sums up quite a few posters on here.

I would rather stick to reality.

Harley - I hope you are right however there has never been any suggestion or indeed any facts about that scenario.

just an RNSR that the bod 'agrees' with the gov.

If I could do an RNSR then I would 'agree' with the gov as well on this .

De' ja' vu dear boy, You said the same thing just before the last placing.

The smoke is Rising !

Where there is smoke there is fire !

Couldn't agree more.

I would say the share price down on average at least 50% every year and now down 99.9999% since listing is the smoke .

I dread to see what the fire is ?

Not sure why my last post disappeared

All it said was that it looks like another placing is on it's way.

Val don't put out these sort of RNS for nothing. They have previous form just before all the other placings.